Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $70.55 | Total: $352.75 |
| 1 | 10 | $59.76 | Total: $597.60 |
| 1 | 25 | $50.63 | Total: $1,265.75 |
| 1 | 50 | $43.16 | Total: $2,158.00 |
| 1 | 100 | $37.35 | Total: $3,735.00 |
Overview
Thymalfasin (Thymosin ?1) (thymosin-alpha 1) is an immunomodulating agent able to enhance the Thl immune response.
Chemical Properties
| Molecular Formula | C129H215N33O55 |
| Molecular Weight | 3108.28 |
| CAS Numbers | 62304-98-7 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | [C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(C)=O)CO)=O)CC(O)=O)=O)C)=O)C)=O)C(C)C)=O)CC(O)=O)=O)[C@@H](C)O)=O)CO)=O)CO)=O)CCC(O)=O)=O)[C@H](CC)C)=O)[C@@H](C)O)=O)[C@@H](C)O)=O)CCCCN)=O)CC(O)=O)=O)CC(C)C)=O)CCCCN)=O)CCC(O)=O)=O)CCCCN)=O)(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC(N)=O)C(O)=O)=O)CCC(O)=O)=O)C)=O)CCC(O)=O)=O)CCC(O)=O)=O)[C@@H](C)C)=O)C(C)C)=O)CCC(O)=O)=O)CCCCN |
Storage and Handling
0C Short Term, -20C Long Term
References
Lao X et al. A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects. Apoptosis. 2015 Oct;20[10] 1307-20.